Rifampicin reduces the AUC of
mefloquine by almost 70%.
The
clinical relevance of this is uncertain, but some suggest that simultaneous use should be avoided to prevent treatment failure and the risk of Plasmodium falciparum resistance to
mefloquine. Until more is known, this would seem a sensible precaution.